Brief: Shield Therapeutics Says Korean Partner Files NDA For Accrufer In Republic Of Korea
28/05/2024 07:21
May 28 (Reuters) - Shield Therapeutics PLC STXS.L :
* SHIELD THERAPEUTICS: KOREAN PARTNER FILES NDA FOR ACCRUFER
IN
REPUBLIC OF KOREA; APPROVAL ANTICIPATED IN 2025
Source text for Eikon: ID:nRSb9601Pa
Further company coverage: STXS.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shield Therapeutics
See all newsBrief: Shield Therapeutics To Assume Full Commercial Control Of ACCRUFeR In US
Shield Therapeutics - Shield assumes full control of ACCRUFeR® in the US
Shield Therapeutics - Interim results for the six months ended 30 Jun 26
Brief: Shield Therapeutics Says On Track For Profitability In 2026; Appoints Michael Jensen As CFO
Shield Therapeutics - Q2 and H1 2026 Trading Update